Intellectia LogoIntellectia
Product
Resources
Markets
News
Partner Program
Pricing
Log inTry for Free
Intellectia Logo
Log in
Intellectia Logo

Product

Features
Financial AI Agent
Stock Technical Analysis
Stock Monitor
Hedge Fund Tracker
AI Screener
Trading Strategies
AI Stock Picker
Swing Trading
Quant AI
Stock Chart Patterns
Daytrading Center
AI Earnings Prediction
Whales Auto Tracker
Backtesting Playground

Resources

Learn
Blog
Earnings
Tutorial
Help Center
Company
About Us
Contact
Press
Reward Program
Partner Program
Tools
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Compare
TradingView
SeekingAlpha

Markets

Trending Stocks
Hot Crypto
Trending News
All Stocks

News

Trading News
Overview
Top News
Daily Market Brief
Earnings
Latest
Newswire
Stock News
Crypto News
Monitor News
Partner ProgramPricing
Start for Free
  1. Home
    2. >
  2. Stock
    3. >
  3. ADUS
stocks logo

ADUS

-
collectAdd to Watchlistadvanced chartAdvanced Chart
$
0.000
0(0.000%)1D
collectadvanced chart
    Overview
    Forecast
    Valuation
    Earnings
High
--
Open
--
VWAP
--
Vol
--
Mkt Cap
--
Low
--
Amount
--
EV/EBITDA(TTM)
--
Total Shares
--
EV
--
EV/OCF(TTM)
--
P/S(TTM)
--
Intellectia AI SwingMax
Intellectia AI SwingMax

Market Estimates

Earnings Estimates
Earnings Estimates
Revenue
YoY Chg
EPS
YoYChg
FY2025Q4
FY2026Q1
FY2026Q2
372.85M
+25.48%
1.725
+24.96%
369.70M
+9.47%
1.581
+11.32%
377.60M
+8.06%
1.680
+12.75%
Estimates Revision
The market is revising Upward the revenue expectations for Addus HomeCare Corporation (ADUS) for FY2025, with the revenue forecasts being adjusted by 1.12% over the past three months. During the same period, the stock price has changed by 0.83%.
Revenue Estimates for FY2025
Revise Upward
up Image
+1.12%
In Past 3 Month
EPS Estimates for FY2025
Revise Upward
up Image
+0.01%
In Past 3 Month
Stock Price
Go Up
up Image
+0.83%
In Past 3 Month
Wall Street analysts forecast ADUS stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ADUS is 132.20 USD with a low forecast of 117.00 USD and a high forecast of 145.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
6 Analyst Rating
Wall Street analysts forecast ADUS stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ADUS is 132.20 USD with a low forecast of 117.00 USD and a high forecast of 145.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.
4 Buy
1 Hold
1 Sell
Moderate Buy
Current: 114.160
sliders
Low
117.00
Averages
132.20
High
145.00
Current: 114.160
sliders
Low
117.00
Averages
132.20
High
145.00
BMO Capital
Market Perform
initiated
$120
2025-11-12
Reason
BMO Capital
Price Target
$120
2025-11-12
initiated
Market Perform
Reason
BMO Capital initiated coverage of Addus HomeCare with a Market Perform rating and $120 price target. The firm says it will look to get more constructive on the shares when concerns around Medicaid funding cuts start to ease. It remains positive on the longer-term macro shift toward in-home care, and Addus HomeCare's positioning.
RBC Capital
Outperform
maintain
$134 -> $139
2025-11-07
Reason
RBC Capital
Price Target
$134 -> $139
2025-11-07
maintain
Outperform
Reason
RBC Capital raised the firm's price target on Addus HomeCare to $139 from $134 and keeps an Outperform rating on the shares. The company reported solid Q3 results, driven by strong 6.6% organic growth in Personal Care and should be well positioned to capitalize on additional M&A opportunities, the analyst tells investors in a research note.
TD Cowen
Buy
maintain
$139 -> $140
2025-11-05
Reason
TD Cowen
Price Target
$139 -> $140
2025-11-05
maintain
Buy
Reason
TD Cowen raised the firm's price target on Addus HomeCare to $140 from $139 and keeps a Buy rating on the shares. The firm updated its model following Q3 results.
Barclays
Andrew Mok
Underweight
maintain
$111 -> $117
2025-11-04
Reason
Barclays
Andrew Mok
Price Target
$111 -> $117
2025-11-04
maintain
Underweight
Reason
Barclays analyst Andrew Mok raised the firm's price target on Addus HomeCare to $117 from $111 and keeps an Underweight rating on the shares following the Q3 report. The firm says that despite a 2% revenue beat, Addus' adjusted EBITDA finished only 1.6% ahead of Street estimates driven by higher cost of services.
UBS
NULL -> Buy
initiated
$145
2025-09-02
Reason
UBS
Price Target
$145
2025-09-02
initiated
NULL -> Buy
Reason
UBS initiated coverage of Addus HomeCare with a Buy rating and $145 price target. The company is positioned to benefit from an aging population with increased co-morbities and a continued shift to low-cost site of care settings, the analyst tells investors in a research note. The firm believes Addus' current valuation provides investors a buying opportunity with the stock discounted as a result of ongoing noise related to Medicaid cuts.
TD Cowen
Buy
maintain
$139
2025-08-07
Reason
TD Cowen
Price Target
$139
2025-08-07
maintain
Buy
Reason
TD Cowen views the selloff in shares of Addus HomeCare (ADUS) on news of Heather Dixon becoming its next President and COO as overdone. Nothing has changed about Addus' positive fundamentals or outlook, the analyst tells investors in a research note. TD reiterates a Buy rating on the shares with a $139 price target, highlighting Addus as a top pick.
See All Ratings

Valuation Metrics

The current forward P/E ratio for Addus Homecare Corp (ADUS.O) is 17.04, compared to its 5-year average forward P/E of 22.29. For a more detailed relative valuation and DCF analysis to assess Addus Homecare Corp 's fair value, click here.
  • Forward PE
  • Forward EV/EBITDA
  • Forward PS

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
Undervalued
5Y Average PE
22.29
Current PE
17.04
Overvalued PE
26.55
Undervalued PE
18.04

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average EV/EBITDA
13.98
Current EV/EBITDA
0.00
Overvalued EV/EBITDA
16.22
Undervalued EV/EBITDA
11.75

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.
StronglyUndervaluedUndervaluedFairOvervaluedStronglyOvervalueddotted line Image
N/A
5Y Average PS
1.51
Current PS
0.00
Overvalued PS
1.73
Undervalued PS
1.28
Financial AI Agent
Financial AI Agent

Financials

Annual
Quarterly
N/A
Total Revenue
N/A
Operating Profit
N/A
Net Income after Tax
N/A
EPS - Diluted
N/A
Free Cash Flow
N/A
Gross Profit Margin - %
N/A
FCF Margin - %
N/A
Net Margin - %
N/A
ROIC

Trading Trends

  • Insider
  • Hedge Fund
  • Congress Trading
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Hedge Fund
Hedge Funds are Neutral. There are no significant trading trends over the last quarter.
Sold
Bought
Congress Trading
Congress are Neutral. There are no significant trading trends over the last month.
Sold
Bought
Insider
Insiders are Neutral. There are no significant trading trends over the last month.
Sold
Bought
AI Stock Picker
AI Stock Picker

ADUS News & Events

Events Timeline

(ET)
2025-11-03
16:24:18
Addus HomeCare Announces Q3 Earnings Per Share of $1.56, Exceeding Consensus Estimate of $1.53
select
2025-08-19 (ET)
2025-08-19
05:04:27
Barclays increases Addus HomeCare price target from $83 to $109
select
2025-08-07 (ET)
2025-08-07
09:21:42
Addus HomeCare appoints Heather Dixon COO
select
Sign Up For More Events
Sign Up For More Events

News

[object Object]
Preview
6.5
11-25NASDAQ.COM
Reasons for Growth Investors to Consider Purchasing Addus HomeCare (ADUS) Immediately

  • Growth Stock Investment: Investors are focusing on growth stocks like Addus HomeCare (ADUS) due to their potential for above-average earnings growth, with ADUS showing a projected EPS growth of 29.5% this year, significantly higher than the industry average of 19.9%.

  • Cash Flow Importance: Addus HomeCare demonstrates strong cash flow growth at 19.5% year-over-year, well above the industry average of 1.5%, which is crucial for funding new projects without relying on external financing.

  • Earnings Estimate Revisions: Positive trends in earnings estimate revisions for Addus HomeCare have contributed to its Zacks Rank of #2 (Buy) and a Growth Score of A, indicating strong potential for stock price appreciation.

  • Investment Recommendations: Zacks Investment Research highlights Addus HomeCare as a solid choice for growth investors, alongside other top stock picks that are expected to see significant gains in the near future.

[object Object]
Preview
4.0
11-06Benzinga
TD Cowen Keeps Buy Rating on Addus HomeCare and Increases Price Target to $140

  • Real-time Intelligence: Benzinga Pro offers the fastest news alerts for traders to stay updated on market movements.

  • Exclusive Content: The platform provides exclusive stories and insights generated by Benzinga reporters for its users.

  • Community Engagement: Over 10,000 serious traders are part of the Benzinga Pro community, enhancing their trading strategies.

  • Market Winning Tools: Benzinga Pro is designed to help traders win in the markets every day with accurate stock market intelligence.

[object Object]
Preview
9.5
11-04NASDAQ.COM
Addus HomeCare Corp. Reports Higher Q3 Profit, Surpassing Expectations

  • Earnings Performance: Addus HomeCare Corp. reported third-quarter earnings of $22.84 million, or $1.24 per share, an increase from $20.16 million, or $1.10 per share, in the same period last year.

  • Adjusted Earnings: The company’s adjusted earnings, excluding items, were $28.72 million or $1.56 per share, surpassing analysts' expectations of $1.53 per share.

  • Revenue Growth: Revenue for the quarter rose by 25.0% to $362.30 million, compared to $289.78 million in the previous year.

  • Analyst Expectations: The reported earnings and revenue exceeded market expectations, indicating strong financial performance for Addus HomeCare Corp. in the third quarter.

Sign Up For More News

People Also Watch

FAQ

arrow icon

What is Addus Homecare Corp (ADUS) stock price today?

The current price of ADUS is 114.16 USD — it has decreased -3.16 % in the last trading day.

arrow icon

What is Addus Homecare Corp (ADUS)'s business?

Addus HomeCare Corporation is engaged in providing home care services. Its segments include Personal Care, Hospice, and Home Health. The Personal Care segment provides non-medical assistance with activities of daily living, to persons who are at increased risk of hospitalization or institutionalization, such as the elderly, chronically ill or disabled. The services it provides include assistance with bathing, grooming, feeding and dressing, medication reminders and others. The Hospice segment provides physical, emotional and spiritual care for people who are terminally ill and related services for their families. The Hospice services it provides include palliative nursing care, social work, spiritual counseling, homemaker services and bereavement counseling. Its Home Health segment provides services that are medical in nature to individuals who may require assistance during an illness or after hospitalization and includes skilled nursing and physical, occupational and speech therapy.

arrow icon

What is the price predicton of ADUS Stock?

Wall Street analysts forecast ADUS stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ADUS is 132.20 USD with a low forecast of 117.00 USD and a high forecast of 145.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

arrow icon

What is Addus Homecare Corp (ADUS)'s revenue for the last quarter?

Addus Homecare Corp revenue for the last quarter amounts to 362.30M USD, increased 25.02 % YoY.

arrow icon

What is Addus Homecare Corp (ADUS)'s earnings per share (EPS) for the last quarter?

Addus Homecare Corp. EPS for the last quarter amounts to 1.24 USD, increased 12.73 % YoY.

arrow icon

What changes have occurred in the market's expectations for Addus Homecare Corp (ADUS)'s fundamentals?

The market is revising Upward the revenue expectations for Addus HomeCare Corporation (ADUS) for FY2025, with the revenue forecasts being adjusted by 1.12% over the past three months. During the same period, the stock price has changed by 0.83%.
arrow icon

How many employees does Addus Homecare Corp (ADUS). have?

Addus Homecare Corp (ADUS) has 6165 emplpoyees as of December 05 2025.

arrow icon

What is Addus Homecare Corp (ADUS) market cap?

Today ADUS has the market capitalization of 2.11B USD.

Intellectia LogoIntellectiaIntellectia LogoIntellectia

Redefine Your Investment Decisions

TwitterTwitterYoutubeYoutubeQuoraQuoraDiscordDiscordLinkedinLinkedinTelegramTelegram
AppStoreGooglePlay

Copyright © 2025 Intellectia.AI. All Rights Reserved.

pci certified logo
Company
HomeContactAbout UsNews Release
Compare
TradingViewSeeking Alpha
Features
Financial AI AgentStock Technical AnalysisStock MonitorHedge Fund TrackerAI ScreenerDaytrading Center
Strategies
AI Stock PickerSwing TradingStock Chart PatternsEarnings TradingDaytrading CenterAI Earnings PredictionQuant AIWhales Auto TrackerBacktesting Playground
Free Tools
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Resource
BlogTutorialEarningsTrending StocksCrypto MarketPartner ProgramTerms of UsePrivacy PolicySecuritySitemap
Start for Free